Keensight Capital Acquires Majority Stake in Isto Biologics
French private equity firm Keensight Capital announced it has agreed to acquire a majority stake in Isto Biologics from Thompson Street Capital Partners. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to help patients heal faster. Isto’s product offering covers six functional areas of unique bone graft solutions, and includes a range of allografts, which are notably used for bone repair in the spine. Isto sells its products to more than 400 hospitals and clinics, which are used in 15,000 surgical procedures per month, primarily in the United States. Keensight Capital is a European growth buyout firm. With more than 25... Read More »
Alcon to Acquire STAAR Surgical Company
According to an August 5 announcement, Alcon has entered into a definitive merger agreement to acquire STAAR Surgical Company. The transaction represents a total equity value of approximately $1.5 billion. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. According to its most recent annual report, STAAR generated $313.9 million in revenue during the fiscal year 2024 and had an EBITDA loss of $8 million. Alcon, a division of Novartis, researches and develops products for eye conditions such as cataracts, glaucoma, retinal diseases and refractive... Read More »
ArchiMed Acquires ZimVie for $730 Million
On July 21, ArchiMed announced that it purchased ZimVie for $730 million. ZimVie stockholders will receive $19 in cash for each share of ZimVie common stock outstanding at the closing of the transaction. ZimVie is a global life sciences leader in the dental market that develops, manufactures and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. Zimvie spun out of Zimmer Biomet in 2022 and has since broken off into smaller pieces. ArchiMed is an independent private equity investment firm focused exclusively on the healthcare industry. It has directly managed and invested in more than... Read More »
PE-Backed TEAM Technologies Buys Duke Empirical
TEAM Technologies announced on July 7 its acquisition of Duke Empirical, Inc. TEAM Technologies is a portfolio company of Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in government-regulated industries. Based in Morgan Hill, California, Duke Empirical is a designer, developer and manufacturer of advanced medical devices for interventional cardiovascular applications. Duke specializes in catheters and minimally invasive delivery systems. Headquartered in Knoxville, Tennessee, with facilities throughout the United States, Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical,... Read More »
Avista Healthcare Partners Acquires EBI from Highridge Medical
Avista Healthcare Partners, a private equity firm focused exclusively on healthcare, has announced its acquisition of EBI, the bone healing division of Highridge Medical. Headquartered in Parsippany, New Jersey, EBI is focused on electrobiology innovations and has a large portfolio of clinically proven, safe and effective implantable and non-invasive bone growth stimulation solutions to support bone regeneration and healing outcomes. Founded in 2005, Avista Healthcare Partners (formerly Avista Capital Partners) is a New York-based private equity firm with more than $9 billion invested in more than 50 growth-oriented healthcare businesses globally. The acquisition marks the 50th platform... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
